Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Curious about accumulating points? Learn which card is best for accumulating points and elevate your rewards strategy effectively.
24,231 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Mortgage rates edge toward 6.8% as markets price in a potential Federal Reserve rate rise this year. Analysts warn hi...
Binance withdraws its Greece bid and says it has one week to secure an EU license. The company reiterates that binanc...
When memory stocks surged on AI demand, one bold strategic move stood out. This article explains how micron just elim...
When a blue-chip name like Microsoft moves, it can shake nerves and portfolios. This guide explains why microsoft sto...
A price-target bump sparked a Friday rally in Johnson & Johnson shares. This guide breaks down what happened, how to ...
When a Tanger director cashed $518,000, investors take notice. This article breaks down insider trades, what signals ...
Google’s looming compute constraint and a $462 billion backlog set the stage for a broader AI access debate. Investor...
Chip shares jumped as risk appetite returned to markets, with Intel and AMD leading a broader move higher on AI infra...
NVIDIA’s market value dips below the $5 trillion threshold as traders reassess AI demand and supply dynamics. Analyst...
Realty Income reports steady AFFO growth, near-full occupancy, and a secure monthly dividend, challenging the narrati...
Ripple (XRP) is facing a critical test near the $1 threshold as ETF flows turn mixed and on-chain signals flicker. Tr...